Epalrestat 150 mg Tablet: View Uses, Benefits, Side Effects.
Epalrestat 150 mg tablet is a well-established oral medication used primarily in the treatment of diabetic peripheral neuropathy—a common complication of long-standing diabetes. As a unique aldose reductase inhibitor, it addresses the root cause of nerve damage by controlling intracellular sorbitol accumulation, offering relief from symptoms like numbness, tingling, pain, and burning sensations in the limbs.
This article will take you through the Epalrestat 150 mg uses, key benefits, working mechanism, dosage, epalrestat 150 mg side effects, and tab Epalrestat 150 mg price in India—making it a complete guide for both patients and healthcare professionals.
What is Epalrestat 150 mg?
Epalrestat is a first-in-class aldose reductase inhibitor developed specifically for managing diabetic neuropathy. It is the only approved oral aldose reductase inhibitor widely used in countries like Japan, India, and South Korea.
Epalrestat 150 mg tablet works by inhibiting the enzyme aldose reductase, which plays a central role in the polyol pathway. In diabetic patients, excess glucose is converted into sorbitol via this pathway, which accumulates in nerve cells and causes oxidative stress and neuronal damage. By inhibiting this conversion, Epalrestat 150 mg helps prevent or reverse nerve damage and restores healthy nerve function.
Epalrestat 150 mg Uses
Understanding the clinical epalrestat 150 mg uses is essential, especially for diabetic patients experiencing nerve-related symptoms. Here's how it helps:
1. Diabetic Peripheral Neuropathy (DPN)
The primary and most recognized use of Epalrestat 150 mg is in the management of diabetic neuropathy, particularly in:
-
Lower limbs: numbness, tingling, burning, and pain in feet or legs
-
Upper limbs: loss of sensation or weakness in hands
Epalrestat helps:
-
Improve nerve conduction velocity
-
Reduce oxidative stress
-
Enhance glucose metabolism in nerves
-
Alleviate pain, paresthesia, and discomfort
2. Autonomic Neuropathy
Though less common, Epalrestat may be useful in treating autonomic symptoms like:
-
Abnormal sweating
-
Constipation or diarrhea
-
Bladder dysfunction
3. Early Nerve Damage in Diabetes
Epalrestat 150 mg is especially effective when started early in diabetes, helping prevent long-term nerve complications by controlling intracellular sorbitol levels.
Key Benefits of Epalrestat 150 mg Tablet
Nerve Protection at Cellular Level
Epalrestat works at the biochemical root cause of nerve damage—unlike other painkillers or vitamins, which only offer symptomatic relief.
Improves Nerve Conduction Velocity
Clinical trials show that long-term use of Epalrestat significantly improves sensory and motor nerve conduction, leading to faster reflexes and better limb function.
Reduces Neuropathic Symptoms
Patients on Epalrestat report reduced burning, tingling, numbness, and muscle cramps, especially in the lower limbs.
Good Safety Profile
Epalrestat 150 mg is generally well-tolerated and suitable for long-term use, unlike many nerve pain medications that cause sedation or weight gain.
Slows Neuropathy Progression
By blocking aldose reductase activity, Epalrestat slows down or reverses the progression of neuropathy in diabetic patients.
How Epalrestat 150 mg Works
Diabetic neuropathy is caused by excess glucose accumulation in nerve cells, leading to sorbitol buildup, oxidative damage, and nerve dysfunction.
Mechanism of Action:
-
Inhibits aldose reductase enzyme
-
Prevents the conversion of glucose → sorbitol
-
Reduces oxidative stress and inflammation in nerves
-
Improves blood flow to peripheral nerves
-
Enhances nerve conduction and sensory function
This disease-modifying mechanism makes Epalrestat unique compared to symptomatic therapies like pregabalin, gabapentin, or duloxetine.
Dosage & Administration of Epalrestat 150 mg
Typical Dosage:
150 mg once daily, or
50 mg three times daily (depending on formulation and doctor's advice)
How to Take:
Take after meals, preferably at the same time daily
Swallow with a glass of water
Do not crush or chew the tablet
Continue taking regularly for best results
Note: Treatment duration is usually 3–6 months, and some patients may need longer therapy depending on the severity of neuropathy.
Epalrestat 150 mg Side Effects
While Epalrestat 150 mg side effects are relatively rare and mild, it’s important to be aware of possible reactions:
Common Side Effects:
Nausea or upset stomach
Skin rash or itching
Headache
Slight elevation in liver enzymes
Rare Side Effects:
Hypersensitivity reactions (rare)
Dizziness or fatigue
Liver dysfunction (in long-term/high-dose use)
Safety Tips:
Monitor liver function if used for more than 3 months
Avoid alcohol, which may aggravate neuropathy
Report any allergic symptoms like swelling or breathlessness to a doctor
Precautions Before Taking Epalrestat 150 mg
-
Pregnancy & Lactation: Not recommended unless prescribed
-
Liver Impairment: Use with caution; regular monitoring advised
-
Children & Elderly: Safe when prescribed with proper monitoring
-
Drug Interactions: No major known drug interactions, but always inform your doctor about current medications
Why Choose Steris Healthcare For Epalrestat 150 mg Tablet?
Steris Healthcare Pvt Ltd stands out as a trusted and quality-driven pharmaceutical company in India, offering reliable formulations like Epalrestat 150 mg Tablet for the effective management of diabetic neuropathy. With a deep commitment to patient well-being and therapeutic excellence, Steris Healthcare manufactures its products in WHO-GMP-certified facilities, ensuring that each tablet meets the highest global standards of safety, efficacy, and consistency.
What sets Steris Healthcare apart is its unwavering focus on research-based formulations and stringent quality control at every stage—from raw material sourcing to final packaging. This meticulous approach guarantees optimal bioavailability, consistent dosing, and superior tolerability of Epalrestat, making it a preferred choice for healthcare professionals across the country.
Steris Healthcare’s Epalrestat 150 mg is specially formulated to help manage diabetic peripheral neuropathy at the root level by inhibiting aldose reductase enzyme activity. It provides real symptom relief from burning, tingling, numbness, and pain in diabetic patients—without causing sedation or cognitive issues common with many neuropathic painkillers.
